Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MBI stock price vs ALNY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ALNY's multiple
Needs ALNY P/S.
Implied fair value · at MBI's multiple
Needs MBI P/S.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: MBI FY 2025 (ended Dec 31, 2025) · ALNY FY 2025 (ended Dec 31, 2025).
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MBIA INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
ALNYLAM PHARMACEUTICALS, INC. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-1.86x
5.22x
Net debt / EBITDA
Leverage against operating earnings
—
4.13x
Cash and equivalents
Liquid reserves on the balance sheet
—
$1.66B
Total debt
Interest-bearing obligations outstanding
$4.17B
$4.12B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ASSURED GUARANTY LTD
MBI vs AGO
RADIAN GROUP INC
MBI vs RDN
AXIS CAPITAL HOLDINGS LTD
MBI vs AXS
CNA FINANCIAL CORP
MBI vs CNA
Moderna, Inc.
MBI vs MRNA
Sarepta Therapeutics, Inc.
MBI vs SRPT
VERTEX PHARMACEUTICALS INC / MA
MBI vs VRTX
BioNTech SE
MBI vs BNTX
ACADIA PHARMACEUTICALS INC
MBI vs ACAD
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
